Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic starts cobalt stent trial:

This article was originally published in Clinica

Executive Summary

Medtronic has begun enrolling patients into a multicentre US trial of its non-stainless steel Driver coronary stent. The study, which will involve around 300 patients, will assess the stent as a treatment for de novo and restenotic lesions in coronary vessels of 3-4mm in diameter. The device, formerly known as S8, is made of a cobalt-based alloy that is designed to be stronger and denser than conventional stainless steel stents, says Medtronic. The alloy may also allow for thinner struts, resulting in a lower profile and better deliverability without compromising radial strength and visibility, the company adds.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts